Compare · IMCC vs RGC
IMCC vs RGC
Side-by-side comparison of IM Cannabis Corp. (IMCC) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IMCC and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.48B, about 2771.9x IMCC ($895,536).
- IMCC has hit the wire 2 times in the past 4 weeks while RGC has been quiet.
- IMCC has more recent analyst coverage (3 ratings vs 0 for RGC).
- Company
- IM Cannabis Corp.
- Regencell Bioscience Holdings Limited
- Price
- $0.14+0.07%
- $5.03+5.57%
- Market cap
- $895,536
- $2.48B
- 1M return
- -
- -71.72%
- 1Y return
- -
- -65.03%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 3
- 0
IMCC
IM Cannabis Corp.
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers strains under the Roma, Dairy Queen, London, Tel Aviv, Paris, and Pandora Box brands; and CBD oil products under the IMC brand. The company also offers its intellectual property related services to the medical cannabis industry. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Latest IMCC
- SEC Form 6-K filed by IM Cannabis Corp.
- IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
- SEC Form 6-K filed by IM Cannabis Corp.
- IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
- SEC Form EFFECT filed by IM Cannabis Corp.
- SEC Form 6-K filed by IM Cannabis Corp.
- IM Cannabis Announces Form F-3 Resale Registration Statement Filing
- SEC Form F-3 filed by IM Cannabis Corp.
- SEC Form 6-K filed by IM Cannabis Corp.
- IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited